FDA reform: new Senate bill. Food and Drug Administration
- PMID: 11363048
Item in Clipboard
FDA reform: new Senate bill. Food and Drug Administration
AIDS Treat News.
.
Abstract
AIDS: Senator Nancy Kassebaum is introducing a Senate bill, focusing on the Food and Drug Administration (FDA), intended to reform the entire drug-development process. The main points of the 76-page draft are highlighted, including the FDA's mission for drug development, reporting procedures, the appeal process, information exchange, restrictions in evaluating effectiveness, exporting of unapproved drugs, and new drug approval standards.
Similar articles
-
The debate on FDA reform: a view from the U.S. Senate. Food and Drug Administration.BETA. 1995 Sep:41-4. BETA. 1995. PMID: 11362892
-
FDA reform in Congress: FDA's concerns. Food and Drug Administration.AIDS Treat News. 1996 Apr 19;(no 245):5-7. AIDS Treat News. 1996. PMID: 11363624
-
The growing debate over FDA reform. Food and Drug Administration.GMHC Treat Issues. 1996 Jan;10(1):1-5. GMHC Treat Issues. 1996. PMID: 11363372
-
Promoting, improving and accelerating the drug development and approval processes.Drug News Perspect. 2008 Jan-Feb;21(1):36-43. Drug News Perspect. 2008. PMID: 18301808 Review.
-
Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).Dermatol Ther. 2009 May-Jun;22(3):204-15. doi: 10.1111/j.1529-8019.2009.01233.x. Dermatol Ther. 2009. PMID: 19453344 Review.